Does acute cessation of trazodone (an antidepressant medication) cause anxiety?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Acute Cessation of Trazodone Can Cause Anxiety as a Withdrawal Symptom

Yes, acute cessation of trazodone can cause anxiety as a withdrawal symptom, and tapering is strongly recommended rather than abrupt discontinuation. 1

Mechanism and Presentation of Trazodone Withdrawal

Trazodone, while not classified as causing dependence in the same way as benzodiazepines or opioids, can still produce withdrawal symptoms when stopped abruptly. The FDA label for trazodone specifically warns against stopping the medication without consulting a healthcare provider 1.

Withdrawal symptoms from trazodone may include:

  • Anxiety (often prominent)
  • Agitation
  • Sleep problems
  • Irritability
  • Mood changes
  • Physical symptoms (headache, dizziness, nausea)

Evidence Supporting Withdrawal Risk

The evidence regarding trazodone withdrawal comes primarily from clinical experience and guidelines rather than large randomized controlled trials. The 2019 Lancet Psychiatry review notes that "abrupt discontinuation of an antidepressant can lead to (sometimes protracted) withdrawal symptoms" 2. While this review focuses more on SSRIs and SNRIs, trazodone shares some similar withdrawal concerns despite its different mechanism of action.

Risk Factors for Trazodone Withdrawal Anxiety

Factors that increase the likelihood of experiencing anxiety upon trazodone cessation include:

  • Longer duration of treatment
  • Higher dosages
  • History of anxiety disorders
  • Abrupt rather than gradual discontinuation
  • Previous withdrawal experiences

Proper Discontinuation Protocol

To minimize withdrawal symptoms including anxiety when stopping trazodone:

  1. Never stop trazodone abruptly - The FDA label explicitly states: "Do not stop taking Trazodone Hydrochloride Tablets without talking to your healthcare provider" 1

  2. Use a gradual tapering approach - The Medication Withdrawal Management guidelines recommend:

    • For long-term users, reducing dose by approximately 10% per month
    • More gradual tapering for those with history of withdrawal symptoms
    • Total tapering period of 3-6 months may be required for complete discontinuation 3
  3. Monitor for withdrawal symptoms - Weekly contact during the active tapering period is necessary to assess for:

    • Emergence of anxiety
    • Sleep disturbances
    • Mood changes
    • Other withdrawal symptoms 3
  4. Adjust tapering schedule as needed - If withdrawal symptoms emerge:

    • Return to previous dose
    • Resume tapering at a slower rate
    • Consider temporary symptomatic management 3

Managing Trazodone Withdrawal Anxiety

If anxiety emerges during trazodone tapering:

  • Slow the taper rate further
  • Consider temporary supportive medications for symptom management
  • Implement non-pharmacological anxiety management techniques (breathing exercises, relaxation techniques)
  • Ensure adequate sleep hygiene as insomnia can worsen anxiety

Special Considerations

Elderly Patients

Elderly patients may be more sensitive to withdrawal effects and may require an even more gradual tapering schedule 3.

Patients with History of Anxiety Disorders

Those with pre-existing anxiety disorders are at higher risk for withdrawal anxiety and may require particularly slow tapering and additional support 3.

Patients on Multiple Psychotropic Medications

Exercise caution when tapering trazodone alongside other psychotropic medications, as this increases complexity and risk of withdrawal symptoms 3.

Common Pitfalls to Avoid

  1. Mistaking withdrawal anxiety for relapse - Withdrawal symptoms can mimic the return of the original condition, leading to inappropriate resumption of full-dose medication

  2. Tapering too quickly - A fixed taper schedule should not be used for all patients; individualization based on response is critical 3

  3. Inadequate monitoring - Weekly contact during active tapering is recommended to identify and address withdrawal symptoms promptly 3

  4. Failing to document the tapering plan - Clear documentation with specific doses and timeline improves adherence and safety 3

By following these evidence-based approaches to trazodone discontinuation, the risk of withdrawal anxiety can be significantly reduced, though not eliminated entirely. The key principle remains that gradual tapering is essential when discontinuing trazodone to minimize withdrawal symptoms including anxiety.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Medication Withdrawal Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.